# Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's

> **NCT05491902** · — · TERMINATED · sponsor: **University of Manchester** · enrollment: 10 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DIAGNOSTIC_TEST:** [C11] Leucine PET scan
- **DIAGNOSTIC_TEST:** [18F] Flutemetamol PET scan
- **DIAGNOSTIC_TEST:** MRI scan

## Key facts

- **NCT ID:** NCT05491902
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-10-09
- **Primary completion:** 2020-10-15
- **Final completion:** 2020-10-15
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** 11C-leucine no longer available at Wolfson Molecular Imaging Centre (after suspension of recruitment due to COVID pandemic)
- **Last updated:** 2022-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05491902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05491902, "Pilot PET Study of Regional Cerebral Protein Synthesis in Alzheimer's". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05491902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*